# Avesta Pharma Private Limited – FDA Inspection, Mar 24, 2023

Source: https://www.keypedia.com/records/fda_inspections/avesta-pharma-private-limited/306cf62d-82e3-445c-9388-f2adc38e0d80
Source feed: FDA_Inspections

> FDA inspection 1202740 of Avesta Pharma Private Limited, March 24, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1202740
- Company Name: Avesta Pharma Private Limited
- Inspection Date: 2023-03-24
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1100312 - 2019-08-22](https://www.keypedia.com/records/fda_inspections/avesta-pharma-private-limited/44038f53-085d-4e57-b10f-6bdb2d9cbe2e)

## Related Officers

- [Lata C. Mathew](https://www.keypedia.com/people/lata-c-mathew/0610a0ef-dcc5-43e7-ab74-2ac54d758beb)

Company: https://www.keypedia.com/companies/avesta-pharma-private-limited/67aa55e0-729d-43b5-b412-fc9fc8b24e24

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c